Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies-Reference-Cited by-同舟云学术

Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies

Published:2015-12 Issue:6 Volume:194 Page:1537-1547
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Crawford E. David¹,Higano Celestia S.²,Shore Neal D.³,Hussain Maha⁴,Petrylak Daniel P.⁵

Affiliation:

1. Department of Urologic Oncology, School of Medicine, University of Colorado Denver, Aurora, Colorado

2. Division of Medical Oncology, Department of Medicine and Department of Urology, School of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington

3. Carolina Urologic Research Center, Myrtle Beach, South Carolina

4. University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

5. Smilow Cancer Center, Yale University, New Haven, Connecticut

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference50 articles.

1. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer (Version 2.2014). Available at http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed June 2014.

2. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

3. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012

4. Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study;Fizazi;Lancet Oncol,2012

5. Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene expression signature of castrate resistant prostate cancer;Gene;2024-10

2. Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer;Nature Communications;2024-02-28

3. Epigenetics as a Key Factor in Prostate Cancer;Advanced Biology;2024-02-20

4. Resistance to taxane chemotherapies in prostate cancer;Therapy Resistance in Prostate Cancer;2024

5. Novel treatment strategies to overcome resistance in prostate cancer;Therapy Resistance in Prostate Cancer;2024